Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Life Science Alliance|August 27, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoderAlice Driessen, Susanne Unger, An-Phi Nguyen, et al.Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.Angewandte Chemie (International Ed. in English)|October 20, 2015
Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia ActivityMatthew B Minus, Wei Liu, Farrukh Vohidov, et al.Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.Pediatric Hematology and Oncology|November 5, 2019
Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysisTing Zhou, M Suzanne Bloomquist, Lizmery Suarez Ferguson, et al.Organic & Biomolecular Chemistry|April 15, 2020
Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitorsMatthew B Minus, Haopei Wang, Jaime O Munoz, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AMLMohammad Javad NajafPanah, Alexandra M Stevens, Michael J Krueger, et al.Biomedicines|February 24, 2024
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of MedicineAlexandra M Stevens, Maci Terrell, Raushan Rashid, et al.Blood Advances|December 20, 2019
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylationAlexandra M Stevens, Michael Xiang, Lisa N Heppler, et al.Cancers|February 25, 2023
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well ToleratedAlexandra McLean Stevens, Eric S Schafer, Minhua Li, et al.Pageof 4